A Comprehensive Systematic Review of The Role of Vasopressors in Early Management of Hemorrhagic Shock
Keywords:
Hemorrhagic shock, vasopressors, norepinephrine, vasopressin, resuscitation, mortality, fluid therapyAbstract
Introduction: The role of vasopressors in the early management of hemorrhagic shock remains controversial, with conflicting evidence from observational studies and randomized controlled trials. This systematic review aims to evaluate the efficacy and safety of early vasopressor administration in adult patients with hemorrhagic shock.
Methods: A systematic review was conducted screening studies based on predefined criteria: adult patients with hemorrhagic shock from any cause, evaluation of any vasopressor agent within the first 24 hours, comparative study designs reporting clinically relevant outcomes. Fifty-eight sources were identified including randomized controlled trials, observational studies, and systematic reviews. Data were extracted on patient populations, vasopressor interventions, mortality outcomes, hemodynamic effects, fluid requirements, and adverse events.
Results: Randomized controlled trials demonstrated that low-dose norepinephrine (<0.3 µg/kg/min) concurrent with fluid resuscitation significantly reduced 24-hour mortality (3% vs 13%, p<0.05) and in-hospital mortality (9% vs 21%, p<0.05) (Mohamed et al., 2024). The AVERT-Shock trial found no mortality difference with low-dose vasopressin but showed reduced blood product requirements (1.4 L vs 2.9 L, p=0.01) (Sims et al., 2019). Observational studies consistently associated vasopressor use with increased mortality (Aoki et al., 2018; Plurad et al., 2011; Fisher et al., 2020), though propensity-score analyses attenuated this association (Gauss et al., 2018). Vasopressors consistently achieved hemodynamic stabilization with improved mean arterial pressure and reduced fluid requirements. Adverse event profiles were similar between groups, with vasopressin associated with fewer deep venous thromboses (Sims et al., 2019).
Discussion: The apparent contradiction between observational and randomized evidence is explained by confounding by indication, where sicker patients preferentially receive vasopressors. Context-dependent effects, agent-specific considerations, and timing of administration significantly influence outcomes. Low-dose vasopressors appear safe when used as adjuncts to—not replacements for—hemorrhage control and volume resuscitation.
Conclusion: Early low-dose vasopressor administration, particularly norepinephrine and vasopressin, may be beneficial in selected patients with hemorrhagic shock, improving hemodynamic stability and reducing transfusion requirements without increasing mortality. Further research is needed to optimize agent selection, dosing strategies, and timing of initiation.
References
A. Patel, and G. Ackland. “Inotropes and Vasopressors for Shock.” DeckerMed Transitional Year Weekly Curriculum™, 2019.
Andrew D. Fisher, M. April, Cord W. Cunningham, and S. Schauer. “Prehospital Vasopressor Use Is Associated with Worse Mortality in Combat Wounded.” Prehospital Emergency Care, 2020.
B. Claes, G. Eerdekens, and L. Al Tmimi. “Insights into Haemorrhagic Shock: A Narrative Review of Pathophysiology and Vasopressor Options.” Acta Anaesthesiologica Belgica, 2024.
Bradley J Haan, Megan L. Cadiz, and Allycia M. Natavio. “Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.” The Annals of Pharmacotherapy, 2020.
C. L. Holmes, and K. Walley. “Vasopressin in the ICU.” Current Opinion in Critical Care, 2004.
Carrie A Sims, D. Holena, Patrick Kim, Jose L. Pascual, Brian Smith, Neils Martin, M. Seamon, et al. “Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial.” JAMA Surgery, 2019.
Cole Bird, Sofie Hass, Ragan Verelst, Fatma Ulusan Sayali, Jessica Reynolds, N. Nazir, and Dhaval Bhavsar. “868 Beyond Resuscitation: Early Vasopressor Use as an Indicator of Clinical Severity in Burn Care Outcomes.” Journal of Burn Care & Research, 2025.
D. Dries. “Vasoactive Drug Support in Septic Shock.” Shock, 2006.
D. Lindberg. “Low-Dose Vasopressin in Patients with Traumatic Hemorrhagic Shock,” 2019.
D. Morales, D. Landry, and M. Oz. “Therapy for Vasodilatory Shock: Arginine Vasopressin,” 2000.
D. Plurad, P. Talving, L. Lam, K. Inaba, D. Green, and D. Demetriades. “Early Vasopressor Use in Critical Injury Is Associated with Mortality Independent from Volume Status.” Journal of Trauma, 2011.
D. Ragoonanan, and Lyudmila Friedman. “Clinical Update on Vasopressors and Titration Strategies.” AACN Advanced Critical Care, 2021.
David Leon, Matt Levy, and Robert Sikorski. “The Role of Selected Adjuncts in the Management of the Bleeding Trauma Patient: Calcium and Vasopressin.” Current Anesthesiology Reports, 2025.
E. Bassi, Marcelo Park, and L. Azevedo. “Therapeutic Strategies for High-Dose Vasopressor-Dependent Shock.” Critical Care Research and Practice, 2013.
E. Laou, Nikolaos Papagiannakis, Androniki Papadopoulou, Theodora Choratta, M. Sakellakis, M. Ippolito, I. Pantazopoulos, A. Cortegiani, and A. Chalkias. “Effects of Vasopressin Receptor Agonists During the Resuscitation of Hemorrhagic Shock: A Systematic Review and Meta-Analysis of Experimental and Clinical Studies.” Journal of Personalized Medicine, 2023.
Emma G. Burke, Bennett William Hartley, Bahaa Succar, and Ryan P Dumas. “Rethinking Vasopressor Use in the Trauma Bay: A Shifting Perspective.” Trauma Surgery & Acute Care Open, 2025.
F. Beloncle, F. Meziani, N. Lerolle, P. Radermacher, and P. Asfar. “Does Vasopressor Therapy Have an Indication in Hemorrhagic Shock?” Annals of Intensive Care, 2013.
Guinot Pierre-Grégoire, Maxime Nguyen, V. Berthoud, Osama Abou-Ara, B. Bouhemad, and Christophe Beyls. “Timing of Vasopressin Initiation Influences Renal Outcomes in Mixed Cardiogenic-Vasodilatory Shock Supported by VA-ECMO.” Anaesthesia Critical Care & Pain Medicine, 2025.
H. Lienhart, K. Lindner, and V. Wenzel. “Developing Alternative Strategies for the Treatment of Traumatic Haemorrhagic Shock.” Current Opinion in Critical Care, 2008.
H. Lienhart, Wenzel, J. Braun, Dörges, M. Dünser, A. Gries, Walter R. Hasibeder, et al. “[Vasopressin for Therapy of Persistent Traumatic Hemorrhagic Shock: The VITRIS.at Study].” Der Anaesthesist, 2007.
H. Raab, K. Lindner, and V. Wenzel. “Preventing Cardiac Arrest During Hemorrhagic Shock with Vasopressin.” Critical Care Medicine, 2008.
H. Strohmenger, A. Krismer, and V. Wenzel. “Vasopressin in Shock States.” Current Opinion in Anaesthesiology, 2003.
Hans Gao, Samuel Garcia, A. Mullan, Daniel Fiterman Molinari, and Aaron Klassen. “From Ambulance to Admission.” International Journal of Paramedicine, 2025.
“Highlights.” JAMA Surgery, 2019.
J. Jentzer, S. Vallabhajosyula, A. Khanna, L. Chawla, L. Busse, and K. Kashani. “Management of Refractory Vasodilatory Shock.” Chest, 2018.
J. Marshall, O. Otegbeye, J. Drapkin, A. Masoudi, C. Fassassi, C. Weiner, A. Likourezos, E. Dickman, and S. Motov. “327 Patients on Vasopressors Transferred from the Emergency Department.” Annals of Emergency Medicine, 2019.
K. Stadlbauer, V. Wenzel, A. Krismer, W. Voelckel, and K. Lindner. “Vasopressin During Uncontrolled Hemorrhagic Shock: Less Bleeding Below the Diaphragm, More Perfusion Above.” Anesthesia and Analgesia, 2005.
K. Uchida, Tetsuro Nishimura, Naohiro Hagawa, Shinichiro Kaga, Tomohiro Noda, Naoki Shinyama, Hiromasa Yamamoto, and Y. Mizobata. “The Impact of Early Administration of Vasopressor Agents for the Resuscitation of Severe Hemorrhagic Shock Following Blunt Trauma.” BMC Emergency Medicine, 2020.
Luis D. Pacheco, Karin A Fox, Corey C. Clifford, F. Behnia, Melissa E Bauer, Antonio Saad, and George R. Saade. “Peripheral Use of Vasopressors in Shock: Clinical Considerations and Recommendations for Use in Obstetrics.” American Journal of Perinatology, 2024.
M. Aoki, T. Abe, D. Saitoh, S. Hagiwara, and K. Oshima. “Use of Vasopressor Increases the Risk of Mortality in Traumatic Hemorrhagic Shock: A Nationwide Cohort Study in Japan.” Critical Care Medicine, 2018.
M. Aoki, T. Abe, S. Hagiwara, and K. Oshima. “Abstract 12367: Increased Risk of Mortality With Vasopressor Use in Traumatic Hemorrhage Shock: A Nationwide Cohort Study in Japan,” 2017.
M. Cucci, Matthew Palmer, Carli Bower, Farjad Siddiqui, Daniel Vazquez, and J. Krizo. “Effect of Early Vasopressin Administration in Refractory Hemorrhagic Shock.” Journal of Trauma Nursing, 2025.
M. Harrison, and Amanda Young. “Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial.” Journal of Emergency Medicine, 2019.
M. Hylands, Augustin Toma, Nicolas Beaudoin, A. Frenette, Frédérick D’Aragon, E. Belley‐Cote, E. Charbonney, et al. “Early Vasopressor Use Following Traumatic Injury: A Systematic Review.” BMJ Open, 2017.
M. Hylands, Augustin Toma, Nicolas Beaudoin, A. Frenette, Frédérick D’Aragon, E. Belley‐Cote, M. Hylander, et al. “Vasopressor Use Following Traumatic Injury: Protocol for a Systematic Review.” BMJ Open, 2017.
M. Hylands, M. Godbout, S. Mayer, W. Fraser, A. Vanasse, Marc-André Leclair, A. Turgeon, et al. “Vasopressor Use Following Traumatic Injury – A Single Center Retrospective Study.” PLoS ONE, 2017.
M. Ng, J. Burgess, and L. Hodge. “Mortality Rate of Trauma Patients Requiring Multiple Vasopressors: Better Than Expected?” The American Surgeon, 2017.
M. Renberg, Tomas Karlsson, Mikael Gellerfors, Jenny Gustavsson, Katrin Wellfelt, and Mattias Günther. “Intramuscular Vasopressin: A Feasible Intervention for Prehospital Hemodynamic Stabilization in Porcine Hemorrhagic Shock and Whole Blood Transfusion.” Transfusion, 2025.
M. Sanui, S. Cohn, D. King, A. Feinstein, A. Varon, and K. Proctor. “A Role for Vasopressin During Resuscitation of Traumatic Shock,” 2004.
Mathew Geevarghese, K. Patel, A. Gulati, and Amaresh K. Ranjan. “Role of Adrenergic Receptors in Shock.” Frontiers in Physiology, 2023.
Matthew Stampfl, and Peter DeBlieux. “A Clinical Review of Vasopressors in Emergency Medicine.” Journal of Emergency Medicine, 2024.
Michael Hessler, P. Arnemann, L. Seidel, Tim G. Kampmeier, S. Rehberg, and C. Ertmer. “ATHOS-3 and the Knights of the Round Table-the Search for the Holy Grail of Vasopressors.” Journal of Thoracic Disease, 2017.
N. Tyagi. “Squeeze the Pipes in Septic Shock.” Journal of Acute Care, 2023.
P. C. M. C. Michael White. “Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has Arrived.” The Annals of Pharmacotherapy, 2023.
P. Fangio, K. Asehnoune, A. Edouard, N. Smail, and D. Benhamou. “Early Embolization and Vasopressor Administration for Management of Life-Threatening Hemorrhage from Pelvic Fracture.” Journal of Trauma, 2005.
Perrine Tubert, Alexandre Kalimouttou, P. Bouzat, Jean-Stéphane David, and Tobias Gauss. “Are Crystalloid-Based Fluid Expansion Strategies Still Relevant in the First Hours of Trauma Induced Hemorrhagic Shock?” Critical Care, 2024.
R. Dutton. “Current Concepts in Hemorrhagic Shock.” Anesthesiology Clinics, 2007.
R. M. Mohamed, Atia Gad Anwar, and Ahmed Aboelhasan Eid. “The Effect of Using Low Dose Norepinephrine Before Hypotensive Resuscitation in Hemorrhagic Shock; a Randomized Controlled Trial.” Anaesthesia, Pain &Amp; Intensive Care, 2024.
Robbie Ley Greaves, Renée Bolot, Andrew Holgate, and Clinton Gibbs. “Safety of Pre‐hospital Peripheral Vasopressors: The SPOTLESS Study (Safety of PrehOspiTaL pEripheral vaSopreSsors).” Emergency Medicine Australasia, 2024.
Robert M. Van Haren, C. Thorson, Evan J. Valle, Gerardo A. Guarch, Jassin M. Jouria, Alexander M. Busko, N. Namias, A. Livingstone, and K. Proctor. “Vasopressor Use During Emergency Trauma Surgery.” The American Surgeon, 2014.
Ross E Orpet, Whitney J Barrett, Kevin A. Kaucher, Christopher B Colwell, and J. Lyng. “Prehospital Trauma Compendium: Vasopressors in Trauma - a Position Statement and Resource Document of NAEMSP.” Prehospital Emergency Care, 2024.
S. Grmec, M. Strnad, D. Čander, and Š. Mally. “A Treatment Protocol Including Vasopressin and Hydroxyethyl Starch Solution Is Associated with Increased Rate of Return of Spontaneous Circulation in Blunt Trauma Patients with Pulseless Electrical Activity.” International Journal of Emergency Medicine, 2008.
S. Smith, A. Newsome, Yanglin Guo, Jason P. Hecht, M. McCurdy, Michael A. Mazzeffi, J. Chow, and S. Kethireddy. “A Multicenter Observational Cohort Study of Angiotensin II in Shock.” Journal of Intensive Care Medicine, 2020.
T. Anand, Omar Hejazi, Adam Nelson, Ben Litmanovich, A. Spencer, Muhammad Haris Khurshid, Arshin Ghaedi, Hamid Hosseinpour, L. Magnotti, and B. Joseph. “Early Vasopressor Requirement Among Hypotensive Trauma Patients: Does It Cause More Harm Than Good?” The American Surgeon, 2024.
Tadaharu Shiozumi, Nobuhiro Sato, Saki Morikawa, Jotaro Tachino, Inaba Mototaka, Naito Hiromichi, Yohei Okada, and Affiliations. “Efficacy and Safety of Vasopressor Use in Adult Patients with Traumatic Hemorrhagic Shock: Systematic Review.” medRxiv, 2025.
Tobias Gauss, Etienne Gayat, A. Harrois, M. Raux, A. Follin, J. Daban, Fabrice Cook, et al. “Effect of Early Use of Noradrenaline on in‐hospital Mortality in Haemorrhagic Shock After Major Trauma: A Propensity‐score Analysis.” British Journal of Anaesthesia, 2018.
V. Wenzel, H. Raab, and M. Dünser. “Arginine Vasopressin: A Promising Rescue Drug in the Treatment of Uncontrolled Haemorrhagic Shock.” Bailliere's Best Practice & Research. Clinical Anaesthesiology, 2008.
Wolfgang G. Voelckel. “Vasopressin in Traumatic Hemorrhagic Shock.” Current Opinion in Anaesthesiology, 2025.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mohamad Fadli, Raka Jati Prasetya, Mutia Juliana (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
